Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Studies genetic causes of brain development disorders such as Aicardi syndrome

Studies genes behind brain malformations and epilepsy, including Aicardi syndrome, to guide future treatments.

Plain-language title generated from the registry record
Registry title: Brain Development Research Program

Key facts

Where
San Francisco, United StatesSee the site

Where in United States

  • University of California San FranciscoSan Francisco, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of California, San Francisco
Trial code
NCT00305305
Record updated
17 August 2026
Original description
Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of brain development that affect the corpus callosum, such as Aicardi syndrome, as well as two additional brain malformations, polymicrogyria and Dandy-Walker malformation. The goal of the investigators' research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients.Read full original descriptionShow less

Disorders of Cerebral Development: A Phenotypic and Genetic Analysis

Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of brain development that affect the corpus callosum, such as Aicardi syndrome, as well as two additional brain malformations, polymicrogyria and Dandy-Walker malformation. The goal of the investigators' research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients.

Inclusion: Clinical diagnosis of agenesis or dysgenesis of the corpus callosum, polymicrogyria, or Dandy-Walker malformation; Should be confirmed by an MRI (Magnetic Resonance Imaging) of the brain.

Exclusion: Fully formed but hypoplastic corpus callosum.

ClinicalTrials.gov NCT00305305